Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer

doi:10.1371/journal.pone.0067128

CNU IR > Pharmacy and Science > Dept. of Biotechnology (including master's program) > Periodical Articles > Item 310902800/27800

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/27800

Title:	Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer
Authors:	Lin, Chun-Mao Fang, Chia-Lang Hseu, You-Cheng Chen, Chun-Liang Wang, Jin-Wun Hsu, Sheng-Lung Tu, Ming-Dao Hung, Shih-Ting Tai, Chein Uen, Yih-Huei Lin, Kai-Yuan
Contributors:	生物科技系
Keywords:	Epithelial-Mesenchymal Transition Colorectal-Cancer Tumor Invasion Breast-Cancer In-Vitro Expression Genes Metastasis Carcinoma Mice
Date:	2013-06
Issue Date:	2014-05-26 10:44:11 (UTC+8)
Publisher:	Public Library Science
Abstract:	Colon cancer is one of the most common malignant cancers worldwide but the current therapeutic approaches for advanced colon cancer are less efficient. This study investigated associations between the expression of nuclear transcription factor SOX4 and various clinicopathologic parameters as well as patients' survival. Expression levels of nuclear SOX4 were analyzed by immunohistochemistry; the data comprised colon tissues from 263 patients with colon cancer. Paired t tests were used to analyze the differences in nuclear SOX4 expression between tumor and non-tumor tissues from each patient. Two-tailed X-2 tests were performed to determine whether the differences in nuclear SOX4 expression and clinicopathologic parameters were significant. Time-to-event endpoints for clinicopathologic parameters were plotted using the Kaplan-Meier method, and statistical significance was determined using univariate log-rank tests. Cox proportional hazard model was used for multivariate analysis to determine the independence of prognostic effects of nuclear SOX4 expression. Overexpression of nuclear SOX4 was significantly correlated with depth of invasion (P = 0.0041), distant metastasis (P < 0.0001), and stage (P = 0.0001). Patients who displayed high expression levels of nuclear SOX4 achieved a significantly poorer disease-free survival rate, compared with patients with low SOX4 expression levels (P < 0.001). Univariate Cox regression analysis showed that overexpression of nuclear SOX4 was a clear prognostic marker for colon cancer (P = 0.001). Overexpression of nuclear SOX4 may be used as a marker to predict the outcome of patients with colon cancer.
Relation:	Plos One, v.8 n.6 pp.e67128
Appears in Collections:	[Dept. of Biotechnology (including master's program)] Periodical Articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	1793	View/Open

Loading...